BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 24465134)

  • 1. Microvascular pericytes in healthy and diseased kidneys.
    Pan SY; Chang YT; Lin SL
    Int J Nephrol Renovasc Dis; 2014 Jan; 7():39-48. PubMed ID: 24465134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of fibrosis: the role of the pericyte.
    Schrimpf C; Duffield JS
    Curr Opin Nephrol Hypertens; 2011 May; 20(3):297-305. PubMed ID: 21422927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel insights into pericyte-myofibroblast transition and therapeutic targets in renal fibrosis.
    Chang FC; Chou YH; Chen YT; Lin SL
    J Formos Med Assoc; 2012 Nov; 111(11):589-98. PubMed ID: 23217594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular mechanisms of tissue fibrosis. 3. Novel mechanisms of kidney fibrosis.
    Campanholle G; Ligresti G; Gharib SA; Duffield JS
    Am J Physiol Cell Physiol; 2013 Apr; 304(7):C591-603. PubMed ID: 23325411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pivotal role of pericytes in kidney fibrosis.
    Kida Y; Duffield JS
    Clin Exp Pharmacol Physiol; 2011 Jul; 38(7):467-73. PubMed ID: 21517936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update of pericytes function and their roles in kidney diseases.
    Chou YH; Pan SY; Shih HM; Lin SL
    J Formos Med Assoc; 2024 Mar; 123(3):307-317. PubMed ID: 37586973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement Activation During Ischemia/Reperfusion Injury Induces Pericyte-to-Myofibroblast Transdifferentiation Regulating Peritubular Capillary Lumen Reduction Through pERK Signaling.
    Castellano G; Franzin R; Stasi A; Divella C; Sallustio F; Pontrelli P; Lucarelli G; Battaglia M; Staffieri F; Crovace A; Stallone G; Seelen M; Daha MR; Grandaliano G; Gesualdo L
    Front Immunol; 2018; 9():1002. PubMed ID: 29875766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1.
    Ren S; Johnson BG; Kida Y; Ip C; Davidson KC; Lin SL; Kobayashi A; Lang RA; Hadjantonakis AK; Moon RT; Duffield JS
    Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1440-5. PubMed ID: 23302695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal Cell Protection of Erythropoietin beyond Correcting The Anemia in Chronic Kidney Disease Patients.
    Nasri H
    Cell J; 2014; 15(4):378-80. PubMed ID: 24381864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphodiesterase inhibitor ameliorates senescent changes of renal interstitial pericytes in aging kidney.
    Kim HD; Kim EN; Lim JH; Kim Y; Ban TH; Lee H; Kim YS; Park CW; Choi BS
    Aging Cell; 2024 Mar; 23(3):e14075. PubMed ID: 38155524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role played by perivascular cells in kidney interstitial injury.
    Rojas A; Chang FC; Lin SL; Duffield JS
    Clin Nephrol; 2012 May; 77(5):400-8. PubMed ID: 22551886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of pericytes: recent insights into kidney fibrosis and microvascular rarefaction.
    Fligny C; Duffield JS
    Curr Opin Rheumatol; 2013 Jan; 25(1):78-86. PubMed ID: 23196325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor β-1 stimulates profibrotic epithelial signaling to activate pericyte-myofibroblast transition in obstructive kidney fibrosis.
    Wu CF; Chiang WC; Lai CF; Chang FC; Chen YT; Chou YH; Wu TH; Linn GR; Ling H; Wu KD; Tsai TJ; Chen YM; Duffield JS; Lin SL
    Am J Pathol; 2013 Jan; 182(1):118-31. PubMed ID: 23142380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis.
    Lin SL; Chang FC; Schrimpf C; Chen YT; Wu CF; Wu VC; Chiang WC; Kuhnert F; Kuo CJ; Chen YM; Wu KD; Tsai TJ; Duffield JS
    Am J Pathol; 2011 Feb; 178(2):911-23. PubMed ID: 21281822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pericyte TIMP3 and ADAMTS1 modulate vascular stability after kidney injury.
    Schrimpf C; Xin C; Campanholle G; Gill SE; Stallcup W; Lin SL; Davis GE; Gharib SA; Humphreys BD; Duffield JS
    J Am Soc Nephrol; 2012 May; 23(5):868-83. PubMed ID: 22383695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exogenous bone marrow derived-putative endothelial progenitor cells attenuate ischemia reperfusion-induced vascular injury and renal fibrosis in mice dependent on pericytes.
    Wang M; Xu H; Li Y; Cao C; Zhu H; Wang Y; Zhao Z; Pei G; Zhu F; Yang Q; Deng X; Zhou C; Guo Y; Wu J; Liao W; Yang J; Yao Y; Zeng R
    Theranostics; 2020; 10(26):12144-12157. PubMed ID: 33204334
    [No Abstract]   [Full Text] [Related]  

  • 17. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis.
    Humphreys BD; Lin SL; Kobayashi A; Hudson TE; Nowlin BT; Bonventre JV; Valerius MT; McMahon AP; Duffield JS
    Am J Pathol; 2010 Jan; 176(1):85-97. PubMed ID: 20008127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting pericyte differentiation as a strategy to modulate kidney fibrosis in diabetic nephropathy.
    Humphreys BD
    Semin Nephrol; 2012 Sep; 32(5):463-70. PubMed ID: 23062987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Putative endothelial progenitor cells do not promote vascular repair but attenuate pericyte-myofibroblast transition in UUO-induced renal fibrosis.
    Yang J; Wang M; Zhu F; Sun J; Xu H; Chong Lee Shin OL; Zhao Z; Pei G; Zhu H; Cao C; He X; Huang Y; Ma Z; Liu L; Wang L; Ning Y; Liu W; Xu G; Wang X; Zeng R; Yao Y
    Stem Cell Res Ther; 2019 Mar; 10(1):104. PubMed ID: 30898157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of pericyte detachment in vascular rarefaction.
    Schrimpf C; Teebken OE; Wilhelmi M; Duffield JS
    J Vasc Res; 2014; 51(4):247-58. PubMed ID: 25195856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.